Welcome to the tag category page for Nerve!
Pregabalin is a medication that is used to treat nerve pain caused by conditions such as diabetes or shingles. It is also used to treat seizures and anxiety. Pregabalin works by slowing down impulses in the brain that cause pain. It comes in the form of capsules or an oral solution. The most common side effects are dizziness, drowsiness, and nausea. Research has shown that pregabalin is effective in reducing pain caused by nerve damage and improving sleep quality.
The iliacus muscle is a flat, triangular muscle located in the iliac fossa and is part of the iliopsoas muscle group. It functions to flex and externally rotate the femur, and helps maintain proper body posture when combined with the psoas muscle. The iliacus muscle can become tight or injured with sports that involve frequent hip flexion, sitting for prolonged periods, or developing trigger points that refer pain to other areas of the body like the groin or down the leg. It is considered one of the strongest hip flexors in the body when combined with the psoas muscle.
The gut–brain axis refers to bidirectional biochemical and neural communication between the gastrointestinal tract and the central nervous system, with gut microbiota acting as a central mediator. Signaling occurs via the enteric nervous system and vagus nerve, immune and inflammatory pathways, enteroendocrine hormones, microbial metabolites and effects on intestinal barrier function. This network links digestion with mood, cognition, stress responses and metabolic regulation, and is implicated in functional gastrointestinal disorders, depression, neurodevelopmental and neurodegenerative conditions, and metabolic disease. Research is advancing rapidly, driving interest in interventions such as dietary modulation, prebiotics and probiotics (sometimes called psychobiotics), fecal microbiota transplantation and targeted microbial therapeutics, but many causal pathways and treatment effects remain unproven or preliminary. Commercial and clinical development faces challenges including variability in individual microbiomes, trial reproducibility, regulatory frameworks and safety. The trend spans pharmaceuticals, diagnostics, nutrition and digital health, and is prompting cross-sector investment in microbiome sequencing, bioinformatics and personalized approaches to brain–gut health.
